Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

SLC7A6OS Inhibitors

SLC7A6OS inhibitors are a class of chemical compounds designed to selectively inhibit the function of the solute carrier family 7 member A6 opposite strand (SLC7A6OS) protein. Although SLC7A6OS is named similarly to members of the solute carrier (SLC) transporter family, its precise role in cellular function remains distinct from typical transport activities. SLC7A6OS is believed to be involved in the regulation of specific cellular pathways, potentially playing roles in RNA processing or gene regulation. Inhibitors targeting SLC7A6OS are designed to interfere with its normal function, allowing researchers to study the effects of its inhibition on cellular processes. These inhibitors typically bind to specific regions of the SLC7A6OS protein, disrupting its interactions with other cellular components or altering its structural conformation, which in turn affects its biological activity.

The development of SLC7A6OS inhibitors relies on detailed knowledge of the protein's structure and function. Techniques such as molecular modeling, protein crystallography, and computational docking are commonly employed to identify potential binding sites for inhibitors on the SLC7A6OS protein. Once these sites are identified, chemical compounds can be designed and optimized to enhance their binding affinity and specificity for SLC7A6OS. These inhibitors are then tested using biochemical assays to assess their efficacy in modulating the function of SLC7A6OS, providing insights into the protein's role in cellular regulation. By studying SLC7A6OS inhibitors, researchers aim to better understand the molecular pathways controlled by this protein and its broader implications in cellular biology. The selective inhibition of SLC7A6OS thus contributes to expanding the knowledge of proteins that play non-transport-related roles within the solute carrier family framework.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Diclofenac acid

15307-86-5sc-357332
sc-357332A
5 g
25 g
$107.00
$292.00
5
(1)

NSAID that can alter cellular ion balances and membrane potentials, which may affect SLC7A6OS function.

1,1-Dimethylbiguanide, Hydrochloride

1115-70-4sc-202000F
sc-202000A
sc-202000B
sc-202000C
sc-202000D
sc-202000E
sc-202000
10 mg
5 g
10 g
50 g
100 g
250 g
1 g
$20.00
$42.00
$62.00
$153.00
$255.00
$500.00
$30.00
37
(1)

AMPK activator that can change cellular energy status, potentially influencing SLC7A6OS activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor that can affect cell signaling pathways and thus indirectly affect SLC7A6OS function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor that can disrupt protein synthesis and trafficking, possibly affecting SLC7A6OS localization or stability.

Verapamil

52-53-9sc-507373
1 g
$367.00
(0)

Calcium channel blocker that can alter calcium homeostasis, potentially affecting SLC7A6OS-regulated transport.

Omeprazole

73590-58-6sc-202265
50 mg
$66.00
4
(1)

Proton pump inhibitor that can change intracellular pH, which may influence SLC7A6OS function.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Tyrosine kinase inhibitor that can modulate signaling pathways, potentially affecting SLC7A6OS activity.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

BCR-ABL tyrosine kinase inhibitor that can affect cell signaling, potentially influencing SLC7A6OS activity.

Torin 1

1222998-36-8sc-396760
10 mg
$240.00
7
(1)

ATP-competitive mTOR inhibitor that can further disrupt protein synthesis, potentially affecting SLC7A6OS.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$108.00
$245.00
$918.00
$49.00
33
(2)

P13K/Akt inhibitor that can affect cell survival pathways, potentially influencing SLC7A6OS activity.